WHO's Anti-Tobacco Marketing Campaign: Protecting Youth from Harm

Aug.02.2022
WHO warns of 40 million young people using tobacco worldwide, with harmful effects on health and mortality rates.

The World Health Organization (WHO) has revealed that over 40 million young people aged 13-15 have started using tobacco, a shocking statistic that highlights the urgent need for action to prevent the harmful effects of this behavior. In response, the WHO has launched a global initiative to expose the tobacco industry's "strategic, aggressive and well-resourced tactics" that target young people, and to equip them with the knowledge and tools to resist these strategies. This anti-marketing campaign aims to strengthen efforts to reduce tobacco demand and implement effective policies worldwide. The tobacco industry has been utilizing new trends to target younger populations, particularly through the use of marketing strategies that encourage the use of new products like e-cigarettes and heated tobacco. However, these products have been proven to be equally harmful as traditional cigarettes, with the same carcinogenic compounds and toxins present in their tobacco content. The variety of flavors available, such as bubblegum and candy, are designed to attract younger audiences and increase the likelihood of them becoming regular smokers later in life. Smoking-related illnesses caused by tobacco result in over 7 million deaths worldwide each year, with approximately 900,000 dying from tobacco smoke-related diseases. Of all smoking-related deaths, more than 40% are from lung cancer, chronic respiratory diseases, and tuberculosis, among other lung-related illnesses.


In 2017, Guyana passed a tobacco control law that follows several provisions of the World Health Organization's convention and aims to become one of the most comprehensive tobacco control laws by implementing a series of policies. These policies include providing a 100% smoke-free environment in all indoor public places, indoor workplaces, public transportation, and designated outdoor areas to prevent people from being exposed to tobacco smoke. It also prohibits all forms of tobacco product advertising, promotion, and sponsorship and requires 60% of tobacco product packaging to display health warning labels, including pictures. Additionally, the law includes a ban on selling tobacco products to minors, selling tobacco products through vending machines, manufacturing and selling toys, candies, and any other tobacco product-shaped commodities. However, there is still much work to be done in fighting against tobacco, as 78% of deaths in Guyana are caused by non-communicable diseases (NCDs), some of which are closely related to tobacco use. While enacting necessary legislation is a good starting point, Guyana's health authorities must address many other challenges if they truly want to reduce the number of people who die or become ill due to tobacco use or exposure. These challenges include monitoring and compliance, stricter enforcement of the law to ensure people are protected from the harms of tobacco use, and addressing the recent trend of highly appealing new tobacco alternatives for young people.


This article is compiled from third-party information and is intended for industry communication and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The translation of this article is solely for industry exchange and research purposes.


Due to limitations in the translation process, the translated article may not fully capture the original expression. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French Anti-Tobacco Group Contre-Feu Calls for Plain Packaging Across All Vaping Products
French anti-tobacco group Contre-Feu said in a statement released on April 14 that e-cigarette manufacturers are encouraging nicotine dependence among young people through targeted marketing and called for concrete measures to protect minors. The group asked for plain packaging for all vaping products, strict regulation of flavor names, and a ban on online sales.
Apr.15 by 2FIRSTS.ai
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Data from convenience insight agency Talysis shows that the value of tobacco, vapes and smoking alternatives in the independent convenience sector fell by 4.4% in the first quarter of 2026, while volume fell by 7.8%. The vaping subcategory declined by 3.9% in value and 10.3% in volume over the same period. Talysis said the impact of the disposable vape ban continues to pressure turnover and footfall.
May.08 by 2FIRSTS.ai
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY announced VIZ on May 6, 2026, describing it as the brand’s first product with a transparent 360-degree wraparound pod.
May.07 by 2FIRSTS.ai